Study of ARO-AAT in Normal Adult Volunteers
NCT03362242
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Alpha 1-Antitrypsin Deficiency
Interventions
DRUG:
ARO-AAT Injection
OTHER:
Sterile Normal Saline (0.9% NaCl)
Sponsor
Arrowhead Pharmaceuticals